Figure 9.Drug susceptibility analysis for chemotherapeutic agents commonly used in the clinic. (A–H) Doxorubicin, sorafenib, pazopanib, gemcitabine, etoposide, rapamycin, temsirolimus, and sunitinib.
Figure 9 — Comprehensive analysis of disulfidptosis-related genes: a prognosis model construction and tumor microenvironment characterization in clear cell renal cell carcinoma | Aging
